A measure to fund billions of dollars in medical aid and research moves to the Senate this week, after flying through the House last week. It pours billions of dollars into the so-called “Cancer Moonshot,” funding to combat the opioid addiction crisis, and many other areas of critical biomedical research.

And while it is enjoying a rare moment of broad bipartisan support, some critics warn that parts of the bill give pharmaceutical and medical device companies a sweetheart deal. 

Click the above audio player to hear the full story.